Valuation: PolyPid Ltd.

Market Cap 117M 105M 97.22M 88.05M 164M 11.16B 166M 1.16B 463M 5.84B 440M 431M 18.54B P/E 2026 *
-9.49x
P/E 2027 * -5.52x
Enterprise Value 78.73M 70.64M 65.31M 59.15M 110M 7.5B 112M 781M 311M 3.92B 295M 289M 12.46B EV / Sales 2026 *
3.74x
EV / Sales 2027 * 8.46x
Free-Float
87.66%
Yield 2026 *
-
Yield 2027 * -
1 day-0.87%
1 week+12.62%
Current month+8.35%
1 month+7.53%
3 months+52.27%
6 months+28.89%
Current year+31.57%
1 week 4.92
Extreme 4.92
5.8
1 month 4.61
Extreme 4.61
5.8
Current year 3.65
Extreme 3.65
5.8
1 year 3.5
Extreme 3.5
5.8
3 years 2.3
Extreme 2.3
9.2
5 years 2.3
Extreme 2.3
257.1
10 years 2.3
Extreme 2.3
583.5
Manager TitleAgeSince
Chief Executive Officer 52 01/07/2022
Director of Finance/CFO 39 -
Chief Tech/Sci/R&D Officer 61 18/08/2025
Director TitleAgeSince
Director/Board Member 84 01/04/2008
Director/Board Member 52 08/08/2022
Director/Board Member 74 01/12/2018
Date Insider Type Main position Quantity % Market Cap. Importance
15/7/26 Free

Director

9,132 0.0896%
15/7/26 Free

Director

9,132 0.0896%
15/7/26 Free

Chairman

9,132 0.0896%
Change 5-day change 1-year change 3-year change Capi.($)
-0.87%+12.62%+53.91%+37.92% 117M
+0.60%+1.37%+57.07%+127.70% 1,143B
+0.81%+5.08%+44.90%+84.23% 647B
+0.39%+0.96%+26.37%+102.65% 506B
-0.05%+1.73%+52.74%+65.27% 384B
-1.00%-6.27%+61.42%+36.81% 350B
+0.34%+1.84%+30.70%+52.69% 293B
-0.45%+1.19%+2.89%+24.92% 265B
+0.55%+2.67%+54.07%+70.99% 242B
+0.38%+3.94%+35.41%+105.25% 197B
Average +0.06%+1.96%+41.95%+70.84% 402.77B
Weighted average by Cap. +0.29%+0.71%+44.50%+86.98%

Financials

2026 *2027 *
Net sales 21.05M 18.89M 17.46M 15.82M 29.55M 2.01B 29.91M 209M 83.17M 1.05B 79.01M 77.34M 3.33B 9.67M 8.67M 8.02M 7.26M 13.57M 921M 13.73M 95.89M 38.19M 482M 36.28M 35.51M 1.53B
Net income -13.59M -12.2M -11.28M -10.21M -19.08M -1.29B -19.31M -135M -53.7M -677M -51.01M -49.93M -2.15B -26.81M -24.05M -22.24M -20.14M -37.63M -2.55B -38.08M -266M -106M -1.34B -101M -98.48M -4.24B
Net Debt -38.47M -34.52M -31.91M -28.9M -53.99M -3.66B -54.65M -382M -152M -1.92B -144M -141M -6.09B -35.44M -31.8M -29.4M -26.62M -49.74M -3.38B -50.34M -351M -140M -1.77B -133M -130M -5.61B
Projected Income Statement - Annual - PolyPid Ltd.
Logo PolyPid Ltd.
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
Employees
72
Date Price Change Volume
29/10/26 US$5.700 -1.21% 93,453
27/10/26 US$5.770 +9.07% 229,102
26/10/26 US$5.290 +0.76% 96,685
23/10/26 US$5.250 +2.34% 104,234
22/10/26 US$5.130 +1.18% 155,520
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - PolyPid Ltd.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
5.770USD
Average target price
11.40USD
Spread / Average Target
+97.57%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - PolyPid Ltd.
  1. Stock Market
  2. Stocks
  3. PYPD Stock